血桂碱
药代动力学
生物碱
化学
尿
代谢物
高效液相色谱法
药理学
色谱法
胃肠道
口服
生物化学
生物
立体化学
作者
Rostislav Večeřa,Bořivoj Klejdus,Pavel Kosina,J. Orolin,Marie Stiborová,Stanislav Smrček,J. Vičar,Zdeněk Dvořák,Jitka Ulrichová A,Vlastimil Kubáň,Pavel Anzenbacher,Vilı́m Šimánek
出处
期刊:Xenobiotica
[Taylor & Francis]
日期:2007-05-01
卷期号:37 (5): 549-558
被引量:38
标识
DOI:10.1080/00498250701230542
摘要
Sanguinarine is an alkaloid with known antibiotic and anti-inflammatory activity and its pharmacokinetics have been studied in the rat after a single oral dose (10 mg kg(-1) body weight). Alkaloid determination in the plasma and liver was carried out by high-performance liquid chromatography-electrospray ionization mass spectrometry (HPLC/ESI-MS). The pharmacokinetic parameters (t(max), c(max), AUC(0-->t) and AUC(0-->infinity)) were determined for sanguinarine and dihydrosanguinarine, the major components detected in plasma. The first step in sanguinarine metabolism in the rat was the reduction of the iminium bond resulting in formation of the less toxic dihydrosanguinarine. Both compounds were completely eliminated from the plasma and liver after 24 h and not detected in urine. After a single oral dose of (3)H-sanguinarine, more than 42% of the ingested radioactivity was present in gastrointestinal tract. Benz[c]acridine, up to date the only sanguinarine metabolite referred to in the literature, was not detected in the plasma, liver or urine.
科研通智能强力驱动
Strongly Powered by AbleSci AI